Medarva Innovations
Medarva Innovations is a healthcare services provider that caters to a diverse range of patients. The organization focuses on delivering quality care and innovative solutions to meet the varied needs of its clientele. By emphasizing patient-centered approaches, Medarva Innovations aims to enhance health outcomes and improve the overall healthcare experience.
1 past transactions
TearSolutions
Series A in 2015
TearSolutions is a biotechnology company focused on developing Lacripep, a synthetic fragment of lacritin, as a topical therapy for dry eye. The treatment uses a short, stable peptide designed to preserve the activity of a natural tear protein, restore basal tearing, and promote corneal surface healing. It targets patients with dry eye symptoms, including those associated with primary Sjögren's syndrome. The company aims to advance Lacripep through clinical development as a replacement therapy for dry eye and has pursued phase II human clinical trials. Based in Charlottesville, Virginia, TearSolutions was founded in 2013.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.